在中血清和红细胞表型.

Physiological and psychiatric investigations into a group of mentally handicapped subjects with self-injurious behaviour.

Journal of mental deficiency research·1980

Serum cholinesterase (pseudocholinesterase) in Down's syndrome: 1. Phenotype frequencies at the E1 and E2 loci.

Journal of mental deficiency research·1977

Serum cholinesterase (pseudocholinesterase) in Down's syndrome: 2. Quantitative levels.

Journal of mental deficiency research·1977

Red cell adenylate kinase phenotypes in the affective disorders.

Human genetics·1977

Plasma acute-phase reactant proteins in tuberose sclerosis.

Journal of mental deficiency research·1976

Serum alpha2-macroglobulin levels in tuberose sclerosis.

Journal of mental deficiency research·1976

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

OTU deubiquitinases as immune-circuit editors: from human immunopathology to therapeutic prioritization.

Frontiers in immunology·2026

Multi-body Fluctuation-Induced Forces Between Membrane Proteins: Insights from Mesoscale Simulations.

Biophysical journal·2026

A safeguarding factor monitors septal pore stability to secure compartmentalization during sporulation in Bacillus subtilis.

Communications biology·2026

Gradient-Guided Graph Contrastive Learning for Mass Spectrometry-Based Proteomics Clustering.

Journal of chemical information and modeling·2026

Conformational Switching on Lipid Interfaces: Lessons from Refolding and Membrane Insertion of Diphtheria Toxin, BCL-2 Apoptotic Regulators and pHLIP.

Chemical reviews·2026

Decoding the secretory blueprint of bone healing: from gradients to regeneration.

Frontiers in cell and developmental biology·2026

相关实验视频

在中血清和红细胞表型.

相关概念视频

Physiological and psychiatric investigations into a group of mentally handicapped subjects with self-injurious behaviour.

Serum cholinesterase (pseudocholinesterase) in Down's syndrome: 1. Phenotype frequencies at the E1 and E2 loci.

Serum cholinesterase (pseudocholinesterase) in Down's syndrome: 2. Quantitative levels.

Red cell adenylate kinase phenotypes in the affective disorders.

Plasma acute-phase reactant proteins in tuberose sclerosis.

Serum alpha2-macroglobulin levels in tuberose sclerosis.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

OTU deubiquitinases as immune-circuit editors: from human immunopathology to therapeutic prioritization.

Multi-body Fluctuation-Induced Forces Between Membrane Proteins: Insights from Mesoscale Simulations.

A safeguarding factor monitors septal pore stability to secure compartmentalization during sporulation in Bacillus subtilis.

Gradient-Guided Graph Contrastive Learning for Mass Spectrometry-Based Proteomics Clustering.

Conformational Switching on Lipid Interfaces: Lessons from Refolding and Membrane Insertion of Diphtheria Toxin, BCL-2 Apoptotic Regulators and pHLIP.

Decoding the secretory blueprint of bone healing: from gradients to regeneration.

相关实验视频

在中血清和红细胞表型.

相关概念视频

相关文章